SECTOR : Medtech
ENTRY DATE : 2012
BUSINESS : Venture Capital
WEB : www.enterome.com
Enterome is a pioneer in the discovery and development of therapeutic solutions based on the interaction between the gut microbiome and the immune system.
Enterome is developing a pipeline of clinical and preclinical candidates (small molecules and peptides) with a focus on cancer, autoimmune, inflammatory and metabolic diseases.
PRESS RELEASE :
05/01/2018 • Enterome raises €32 million ($38.5 million) in a Series D financing